- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Antifibrotic Therapies in the Liver ; volume:35 ; number:02 ; year:2015 ; pages:184-198
Seminars in liver disease ; 35, Heft 02 (2015), 184-198
- Contributor
-
Mehal, W. Z.
Schuppan, D.
- DOI
-
10.1055/s-0035-1550055
- URN
-
urn:nbn:de:101:1-2019011109480190791657
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mehal, W. Z.
- Schuppan, D.
Other Objects (12)
Antifibrotic therapies to control cardiac fibrosis
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver
Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis : potential implications for antifibrotic therapies
Novel regional therapies for liver tumors
Antifibrotic effects of an sGC activator in rat models of liver fibrosis
Integrative Bioinformatic Analyses of Global Transcriptome Data Decipher Novel Molecular Insights into Cardiac Anti-Fibrotic Therapies
The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis
Antifibrotic therapy to normalize the tumor microenvironment
Noncolorectal, Nonneuroendocrine Liver Metastases : Diagnosis and Current Therapies
Antifibrotic therapy in the liver by adenovirus mediated expression of a TGF β1 [beta 1] antisense mRNA
Antifibrotic therapies to control cardiac fibrosis
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver
Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis : potential implications for antifibrotic therapies
Novel regional therapies for liver tumors
Antifibrotic effects of an sGC activator in rat models of liver fibrosis
Integrative Bioinformatic Analyses of Global Transcriptome Data Decipher Novel Molecular Insights into Cardiac Anti-Fibrotic Therapies
The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis
Antifibrotic therapy to normalize the tumor microenvironment
Noncolorectal, Nonneuroendocrine Liver Metastases : Diagnosis and Current Therapies
Antifibrotic therapy in the liver by adenovirus mediated expression of a TGF β1 [beta 1] antisense mRNA
Antifibrotic therapies to control cardiac fibrosis
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver
Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis
Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis : potential implications for antifibrotic therapies
Novel regional therapies for liver tumors
Antifibrotic effects of an sGC activator in rat models of liver fibrosis
Integrative Bioinformatic Analyses of Global Transcriptome Data Decipher Novel Molecular Insights into Cardiac Anti-Fibrotic Therapies
The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis
Antifibrotic therapy to normalize the tumor microenvironment
Noncolorectal, Nonneuroendocrine Liver Metastases : Diagnosis and Current Therapies